Ticker,Title,Link
NBIX,Neurocrine’s Robust Drug Pipeline and Strategic Launch Preparations Bolster Buy Rating,9/6/2024 9:47:18 AM
NBIX,Buy Rating Affirmed for Neurocrine Biosciences Amidst Therapeutic Development and Valuation Prospects,8/30/2024 6:56:54 AM
NBIX,"Neurocrine upped to overweight by Piper, sees '568 as still viable",8/29/2024 2:30:37 PM
NBIX,Hold Rating on Neurocrine Amid Competitive Concerns for NBI-568,8/28/2024 8:45:17 PM
NBIX,Buy Rating Affirmed on Neurocrine’s Potential and Robust Valuation Model,8/21/2024 10:27:03 AM
NBIX,"Analysts Offer Insights on Healthcare Companies: Bluebird Bio (BLUE), ImmunityBio (IBRX) and Neurocrine (NBIX)",8/19/2024 12:12:22 PM
NBIX,Buy Recommendation for Neurocrine: A Risk-Reward Analysis of Pipeline Prospects and Valuation,8/16/2024 6:35:44 AM
NBIX,Buy Rating Affirmed for Neurocrine Amid Soaring Ingrezza Sales and Promising Growth Prospects,8/5/2024 6:17:56 AM
NBIX,Morgan Stanley Sticks to Their Buy Rating for Neurocrine (NBIX),8/2/2024 12:51:25 PM
NBIX,Neurocrine’s Strong Q2 Performance and Clinical Pipeline Reinforce Buy Rating,8/1/2024 7:06:33 PM
NBIX,Neurocrine Biosciences Q2 2024 Earnings Preview,7/31/2024 4:20:21 PM
NBIX,"Analysts Are Bullish on Top Healthcare Stocks: Sanofi (SNYNF), Neurocrine (NBIX)",7/30/2024 6:04:22 AM
NBIX,Neurocrine Biosciences Launches INGREZZA SPRINKLE Capsules - Quick Facts ,7/18/2024 3:11:40 PM
NBIX,Morgan Stanley Keeps Their Buy Rating on Neurocrine (NBIX),7/12/2024 12:26:42 PM
NBIX,Cracking The Code: Understanding Analyst Reviews For Neurocrine Biosciences,7/10/2024 9:00:20 PM
NBIX,Neurocrine’s Market Resilience Solidifies Buy Rating Amid Industry Challenges,7/9/2024 7:15:17 PM
NBIX,Maintaining Hold on Neurocrine Biosciences Amid Efficacy Concerns and Competitive Pressures,7/2/2024 1:28:46 AM
NBIX,FDA sets target action dates for Neurocrine drug applications,7/1/2024 3:55:27 PM
NBIX,Neurocrine (NBIX) Receives a Hold from Mizuho Securities,6/21/2024 12:27:06 PM
NBIX,Wall Street Analysts Are Neutral on Top Healthcare Picks,6/19/2024 5:10:27 AM
NBIX,"Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Patterson Companies (PDCO) and Neurocrine (NBIX)",6/18/2024 9:01:14 AM
NBIX,7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline,6/17/2024 7:27:56 PM
NBIX,Buy Rating for Neurocrine Biosciences Backed by Strong Pipeline and Financial Health,6/14/2024 4:25:16 AM
NBIX,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Addus Homecare (ADUS), Neurocrine (NBIX) and Petmed Express (PETS)",6/12/2024 10:51:40 AM
NBIX,"Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Jazz Pharmaceuticals (JAZZ) and Neurocrine (NBIX)",6/6/2024 10:40:15 AM
NBIX,Maintaining Buy Rating for Neurocrine Amid Competitive Landscape and Promising Pipeline Developments,6/4/2024 10:18:33 AM
NBIX,Neurocrine Biosciences' CAHtalyst Phase 3 Studies Of Crinecerfont  Meet Primary Goals ,6/3/2024 2:19:19 PM
NBIX,Oppenheimer Reaffirms Their Buy Rating on Neurocrine (NBIX),5/29/2024 11:35:38 AM
NBIX,"MNMD, NBIX and OCUL are among after hour movers",5/28/2024 9:04:47 PM
NBIX,"Viking, CRISPR, Intellia among potential M&A targets: Wells Fargo",5/25/2024 2:24:03 PM
NBIX,Neurocrine Biosciences: A Strong Buy on Superior Clinical Outcomes and Promising Pipeline,5/23/2024 12:56:44 PM
NBIX,Wall Street Analysts Are Bullish on Top Healthcare Picks,5/16/2024 10:40:49 AM
NBIX,Evercore says biotech ‘winter is finally thawing’,5/14/2024 3:24:32 PM
NBIX,Neurocrine (NBIX) Receives a Buy from Wells Fargo,5/13/2024 10:47:31 PM
NBIX,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Arbutus Biopharma (ABUS), Neurocrine (NBIX) and Bausch Health Companies (BHC)",5/3/2024 11:11:28 AM
NBIX,Buy Rating on Neurocrine: Strong Foundations and Promising Pipeline,5/2/2024 12:16:25 PM
NBIX,Cracking The Code: Understanding Analyst Reviews For Neurocrine Biosciences,5/1/2024 7:00:49 PM
NBIX,Neurocrine Biosciences Q1 2024 Earnings Preview,4/30/2024 3:50:12 PM
NBIX,RBC Capital Remains a Hold on Neurocrine (NBIX),4/29/2024 10:52:50 AM
NBIX,Promising Outlook for Neurocrine’s NBI-‘845 in MDD Market Based on Strong Phase 2 Results and Competitive Positioning,4/26/2024 7:15:23 AM
NBIX,Neurocrine launches CAH community website ahead of FDA filing,4/24/2024 11:08:44 PM
NBIX,Neurocrine succeeds in mid-stage trial for Takeda-partnered depression drug,4/23/2024 6:22:14 PM
NBIX,Sentia Medical Sciences and Neurocrine Biosciences extend research collaboration,4/16/2024 8:09:56 PM
NBIX,Small and midcap pair trades for every sector - Oppenheimer,4/15/2024 10:38:19 AM
NBIX,"Analysts Offer Insights on Healthcare Companies: Avita Medical (RCEL), Summit Therapeutics (SMMT) and Neurocrine (NBIX)",4/11/2024 11:30:43 AM
NBIX,Where Neurocrine Biosciences Stands With Analysts,4/10/2024 5:00:40 PM
NBIX,"Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Shandong Weigao Group Medical Polymer Co (OtherSHWGF) and Cormedix (CRMD)",4/9/2024 4:30:26 AM
NBIX,Analysts Offer Insights on Healthcare Companies: Icon (ICLR) and Neurocrine (NBIX),4/8/2024 8:31:48 AM
NBIX,Wells Fargo Reaffirms Their Hold Rating on Neurocrine (NBIX),4/3/2024 9:16:42 AM
NBIX,Biotech Stocks Facing FDA Decision In April 2024 ,3/28/2024 3:54:25 PM
NBIX,Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform,3/19/2024 7:16:11 PM
NBIX,"Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Arcellx Inc (ACLX) and Exact Sciences (EXAS)",3/15/2024 5:42:27 AM
NBIX,Maintaining Hold Rating for Neurocrine Biosciences Amid Reduced Competition and Long-Term Market Potential,3/14/2024 11:15:53 AM
NBIX,In-Depth Examination Of 8 Analyst Recommendations For Neurocrine Biosciences,3/13/2024 9:00:29 PM
NBIX,3 Cutting-Edge Biotech Stocks Sitting on the Brink of Success,3/6/2024 9:45:00 PM
NBIX,"Analysts Are Bullish on These Healthcare Stocks: Tenet Healthcare (THC), Moderna (MRNA)",3/1/2024 1:40:12 PM
NBIX,RBC Capital Keeps Their Hold Rating on Neurocrine (NBIX),2/22/2024 12:32:21 PM
NBIX,Positive Outlook for Neurocrine Biosciences with Underappreciated Pipeline Potential,2/13/2024 10:41:17 AM
NBIX,Why This Teva Pharmaceutical Analyst Is Turning Bullish On The Austedo Franchise,2/12/2024 5:54:03 PM
NBIX,Neurocrine Biosciences: A Strong Buy on Robust Financial Performance and Promising Drug Pipeline,2/9/2024 5:56:32 AM
NBIX,Breaking Down Neurocrine Biosciences: 8 Analysts Share Their Views,2/8/2024 3:00:26 PM
NBIX,Neurocrine Biosciences Buy Rating Affirmed Amid Solid Ingrezza Growth and Promising Pipeline,2/7/2024 11:35:15 PM
NBIX,Neurocrine Biosciences Q4 2023 Earnings Preview,2/6/2024 6:15:43 PM
NBIX,"Analysts Offer Insights on Healthcare Companies: Terns Pharmaceuticals (TERN), Merck & Company (MRK) and Neurocrine (NBIX)",2/5/2024 9:31:38 AM
NBIX,"Analysts Are Bullish on Top Healthcare Stocks: Neurocrine (NBIX), Crinetics Pharmaceuticals (CRNX)",2/2/2024 1:00:24 PM
NBIX,"Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Vertex Pharmaceuticals (VRTX) and Neurocrine (NBIX)",1/31/2024 10:50:44 AM
NBIX,Big Pharma earnings season in spotlight amid positive sentiment,1/28/2024 5:00:53 PM
NBIX,Unveiling 13 Analyst Insights On Neurocrine Biosciences,1/23/2024 4:00:46 PM
NBIX,"Analysts’ Top Healthcare Picks: Veru (VERU), Neurocrine (NBIX)",1/12/2024 1:01:52 PM
NBIX,"Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Neurocrine (NBIX) and Globus Medical (GMED)",1/10/2024 12:10:57 PM
NBIX,RBC Capital Sticks to Their Hold Rating for Neurocrine (NBIX),1/6/2024 1:45:49 AM
NBIX,Neurocrine Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference,1/2/2024 10:01:00 PM
NBIX,3 Stocks at the Forefront of Medical Innovation,12/26/2023 1:23:09 AM
NBIX,"Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Intuitive Surgical (ISRG) and Neurocrine (NBIX)",12/19/2023 11:10:28 AM
NBIX,The 3 Most Undervalued Biotech Stocks to Buy in December,12/15/2023 7:30:49 PM
NBIX,"Analysts Offer Insights on Healthcare Companies: Centene (CNC), Neurocrine (NBIX) and Exelixis (EXEL)",12/13/2023 9:51:07 AM
NBIX,Analyst Expectations for Neurocrine Biosciences's Future,12/7/2023 5:00:40 PM
NBIX,Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX) and CVS Health (CVS),12/6/2023 3:20:08 PM
NBIX,Neurocrine Biosciences Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Crinecerfont in Congenital Adrenal Hyperplasia,12/5/2023 10:01:00 PM
NBIX,"Neurocrine Biosciences to Host Analyst Day on December 5, 2023",12/1/2023 1:00:00 PM
NBIX,Neurocrine Biosciences Reaches Settlement On INGREZZA ANDA Litigation ,11/13/2023 1:09:39 PM
NBIX,Why Is Neurocrine Biosciences Stock Trading Lower Today?,11/10/2023 7:43:06 PM
NBIX,Analysts Offer Insights on Healthcare Companies: Xilio Therapeutics (XLO) and Neurocrine (NBIX),11/9/2023 11:52:03 PM
NBIX,Neurocrine Biosciences Launches Interactive Digital Tool for use by Healthcare Providers to Help Expand Education on Identifying and Diagnosing Tardive Dyskinesia,11/8/2023 10:05:00 PM
NBIX,3 Biotech Moonshots to Bet on the Future of Health,11/6/2023 11:51:03 PM
NBIX,Stifel Nicolaus Remains a Buy on Neurocrine (NBIX),11/3/2023 2:06:50 AM
NBIX,Neurocrine Biosciences® Presents INGREZZA® (valbenazine) Capsules Interim Data Demonstrating Sustained Improvements in Chorea Associated With Huntington's Disease Through Week 50 at Huntington Stu...,11/2/2023 1:30:00 PM
NBIX,Raymond James Maintains Outperform Rating for Neurocrine Biosciences: Here's What You Need To Know,11/1/2023 6:00:11 PM
NBIX,Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC) and Neurocrine (NBIX),10/31/2023 6:40:10 PM
NBIX,Here's what Wall Street expects from Neurocrine Biosciences's earnings report,10/30/2023 3:01:13 PM
NBIX,Neurocrine Biosciences: A Strong Buy Based on Impressive Returns and Promising Clinical Developments,10/23/2023 11:35:34 PM
NBIX,Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV) and Neurocrine (NBIX),10/19/2023 10:12:03 AM
NBIX,Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2023 Financial Results,10/10/2023 10:01:00 PM
NBIX,"Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Bausch Health Companies (BHC) and Intra-Cellular Therapies (ITCI)",10/9/2023 12:31:30 PM
NBIX,What 22 Analyst Ratings Have To Say About Neurocrine Biosciences,10/6/2023 9:00:54 PM
NBIX,Neurocrine Biosciences: Positive Clinical Data Reinforces Buy Rating – A Detailed Review,10/5/2023 7:45:49 PM
NBIX,Neurocrine Biosciences Presents Post Hoc Data Analysis in Congenital Adrenal Hyperplasia at ESPE 2023,9/21/2023 3:15:00 PM
NBIX,"Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Staar Surgical (STAA) and Icon (ICLR)",9/15/2023 6:20:29 AM
NBIX,Neurocrine : FDA Accepts NDA For Ingrezza Oral Granules Sprinkle Formulation ,9/14/2023 2:57:43 PM
NBIX,Analyst Expectations for Neurocrine Biosciences's Future,9/13/2023 9:00:48 PM
NBIX,Spruce Bio gains after Neurocrine’s Phase 3 win for genetic disorder drug,9/12/2023 6:05:37 PM
NBIX,Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1117570 in Healthy Adults,9/11/2023 2:30:00 PM
NBIX,"Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF), Neurocrine (NBIX) and Arcus Biosciences (RCUS)",9/5/2023 10:11:13 AM
NBIX,Neurocrine Biosciences to Present at Upcoming Investor Conferences in September,8/31/2023 10:01:00 PM
NBIX,Neurocrine Biosciences Presents Data at MDS International Congress of Parkinson's Disease and Movement Disorders® Demonstrating Comparable Improvement Over Time in Tardive Dyskinesia Severity and ...,8/29/2023 2:30:00 PM
NBIX,Neurocrine Reveals New Data On Ingrezza With Improvements In HD Chorea In Huntington's Disease ,8/28/2023 3:05:00 PM
NBIX,FDA Greenlights Expanded Use Of Neurocrine Biosciences' Ingrezza: Analysts Weigh In Depression Warning,8/21/2023 8:24:35 PM
NBIX,Neurocrine (NBIX) Gets a Buy from Goldman Sachs,8/18/2023 10:45:06 PM
NBIX,"Catalyst Watch: Eyes On Walmart, Cisco, FOMC minutes and 13F filings",8/11/2023 7:00:30 PM
NBIX,Analyst Ratings for Neurocrine Biosciences,8/2/2023 8:00:20 PM
NBIX,Neurocrine Biosciences Inc Q2 Earnings Summary,8/1/2023 1:07:51 PM
NBIX,Neurocrine Biosciences Q2 2023 Earnings Preview,7/31/2023 6:33:35 PM
NBIX,Neurocrine (NBIX) Gets a Hold from Mizuho Securities,7/20/2023 8:45:07 AM
NBIX,"Eli Lilly, Merck among top pharma picks in Barclays Q2 preview",7/16/2023 4:00:00 PM
NBIX,Bank of America Securities Keeps Their Buy Rating on Neurocrine (NBIX),7/14/2023 10:25:06 AM
NBIX,Neurocrine Biosciences Announces Appointment of Christine A. Poon to Board of Directors,7/11/2023 10:05:00 PM
NBIX,BMO upgrades Neurocrine to market perform on Ingrezza outlook,7/7/2023 6:25:19 PM
NBIX,Confidence Boost From Ingrezza Sales: Analyst Upgrades Neurocrine Biosciences,7/6/2023 9:12:28 PM
NBIX,Analysts Have Conflicting Sentiments on These Healthcare Companies: Neurocrine (NBIX) and Catalent (CTLT),7/1/2023 1:50:12 AM
NBIX,Expert Ratings for Neurocrine Biosciences,6/30/2023 10:01:02 PM
NBIX,"Diurnal Ltd., a Neurocrine Biosciences Company, Presents Phase 3 Extension Study Data for Modified-Release Hydrocortisone in Patients with Congenital Adrenal Hyperplasia at ENDO 2023",6/15/2023 2:30:00 PM
NBIX,Neurocrine Biosciences to Present at the Goldman Sachs 44th Annual Global Healthcare Conference,6/8/2023 10:01:00 PM
NBIX,What 15 Analyst Ratings Have To Say About Neurocrine Biosciences,6/5/2023 11:01:17 PM
NBIX,Neurocrine Biosciences Presents INGREZZA® (valbenazine) Capsules Data on Tardive Dyskinesia Improvement Regardless of Baseline Antipsychotic Use at 2023 Psych Congress Elevate,6/2/2023 2:30:00 PM
NBIX,Neurocrine sees August FDA action date for valbenazine for chorea,5/19/2023 3:46:36 PM
NBIX,Neurocrine Biosciences Presents INGREZZA® (valbenazine) Capsules Data on Long-Term Improvements and Psychiatric Stability in Patients With Tardive Dyskinesia and Schizophrenia or Schizoaffective D...,5/15/2023 2:30:00 PM
NBIX,Neurocrine Biosciences Presents Data on Treatment of Patients with Congenital Adrenal Hyperplasia at ECE 2023,5/12/2023 2:30:00 PM
NBIX,Neurocrine (NBIX) Receives a Hold from SVB Securities,5/5/2023 3:15:45 PM
NBIX,"Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023",5/4/2023 5:00:45 PM
NBIX,Goldman Sachs Sticks to Their Buy Rating for Neurocrine (NBIX),5/3/2023 8:35:05 PM
NBIX,Neurocrine Biosciences to Present at the Bank of America Securities 2023 Healthcare Conference,5/2/2023 10:01:00 PM
NBIX,Neurocrine Biosciences Supports the Mental Health Community During Tardive Dyskinesia Awareness Week,5/1/2023 2:30:00 PM
NBIX,3 Pharma Stocks That Could See a Surge in Demand in 2023,4/24/2023 7:55:10 PM
NBIX,"Alnylam, Intra-Cellular among potential biotech take-out targets - RBC",4/19/2023 1:01:34 PM
NBIX,"Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), Ionis Pharmaceuticals (IONS) and Neurocrine (NBIX)",4/18/2023 12:30:28 PM
NBIX,What 15 Analyst Ratings Have To Say About Neurocrine Biosciences,4/17/2023 7:01:59 PM
NBIX,Analysts Have Conflicting Sentiments on These Healthcare Companies: Cytokinetics (CYTK) and Neurocrine (NBIX),4/14/2023 12:10:15 AM
NBIX,Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2023 Financial Results,4/12/2023 10:01:00 PM
NBIX,RBC Capital Keeps Their Hold Rating on Neurocrine (NBIX),4/8/2023 1:45:31 AM
NBIX,Expert Ratings for Neurocrine Biosciences,3/30/2023 7:01:05 PM
NBIX,Teva in pact with Neurocrine to delay Ingrezza generics,3/29/2023 10:54:35 AM
NBIX,Neurocrine (NBIX) Gets a Hold from SVB Securities,3/28/2023 10:05:40 AM
NBIX,Citigroup Sticks to Its Buy Rating for Neurocrine (NBIX),3/22/2023 9:55:13 AM
NBIX,Neurocrine Biosciences to Present at the Stifel 2023 CNS Days,3/21/2023 9:01:00 PM
NBIX,3 Growth Stocks That Could Disrupt the Healthcare Industry,3/13/2023 7:29:48 PM
NBIX,Neurocrine Biosciences Announces Results from the Real-World RE-KINECT™ Study Published in the Journal of Patient-Reported Outcomes Demonstrating the Effects of Possible Tardive Dyskinesia (TD) on...,3/9/2023 10:30:00 PM
NBIX,Neurocrine Biosciences to Participate at Investor Conferences in March,3/8/2023 10:01:00 PM
NBIX,"‘2023 Rally Was a Bull Trap,’ Says Morgan Stanley. But These Stocks Still Have Upside",3/6/2023 12:06:14 AM
NBIX,Pharma R&D funding soared to a new record in 2022 as oncology candidates dominate pipelines,3/4/2023 6:45:00 PM
NBIX,Analyst Expectations for Neurocrine Biosciences's Future,3/3/2023 7:00:55 PM
NBIX,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Neurocrine (NBIX), Lantheus (LNTH) and Sanofi (OtherSNYNF)",2/10/2023 4:50:12 AM
NBIX,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (INCY), Neurocrine (NBIX) and Deciphera Pharmaceuticals (DCPH)",2/9/2023 2:10:20 AM
NBIX,Wall Street Analysts Are Bullish on Top Healthcare Picks,2/8/2023 4:30:26 AM
NBIX,Neurocrine Biosciences to Present at the SVB Securities Global Biopharma Conference,2/7/2023 10:01:00 PM
NBIX,Neurocrine Biosciences Inc Q4 Earnings Summary,2/6/2023 1:33:07 PM
NBIX,"Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023",2/3/2023 4:00:43 PM
NBIX,Mizuho Securities Sticks to Their Hold Rating for Neurocrine (NBIX),1/30/2023 9:15:09 AM
NBIX,7 A-Rated Stocks to Buy for Less Than $25,1/24/2023 11:15:09 AM
NBIX,Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2022 Financial Results,1/17/2023 10:01:00 PM
NBIX,Needham Sticks to Its Hold Rating for Neurocrine (NBIX),1/12/2023 11:05:09 AM
NBIX,Voyager Therapeutics (VYGR) Stock Gains 18% on Gene Therapy Deal,1/9/2023 4:24:25 PM
NBIX,Neurocrine Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference,1/3/2023 10:01:00 PM
NBIX,"Catalyst watch: Tesla deliveries, CES reveals and healthcare updates lead off 2023",12/30/2022 7:00:00 PM
NBIX,Have A Look At William Blair's Top Biotech Picks For 2023,12/25/2022 7:32:30 PM
NBIX,Neurocrine Biosciences Announces U.S. FDA Accepts Supplemental New Drug Application for Valbenazine as a Treatment for Chorea Associated with Huntington Disease,12/22/2022 10:01:00 PM
NBIX,"Despite Neurocrine's Epilepsy Drug Missing Primary Goal In Pediatric Trial, Analyst Sees Strong Growth",12/7/2022 2:00:42 PM
NBIX,Neurocrine Biosciences Provides Update on Phase 2 Study of NBI-827104 in Pediatric Patients with Epileptic Encephalopathy with Continuous Spike-and-Wave During Sleep,12/6/2022 10:01:00 PM
NBIX,Neurocrine Biosciences Presents Demographic and Clinical Characteristics Data of Pediatric Patients with SCN8A-Related Epilepsies at AES 2022,12/2/2022 2:30:00 PM
NBIX,Heska To $165? Plus BTIG Cuts PT On This Stock By 67%,11/14/2022 2:21:14 PM
NBIX,Neurocrine Biosciences to Present at Upcoming Healthcare Conferences,11/8/2022 10:01:00 PM
NBIX,Neurocrine Biosciences Presents Data on In Vitro Dissolution Performance of INGREZZA® (valbenazine) Capsules at the American Society of Consultant Pharmacists (ASCP) 2022 Annual Meeting,11/3/2022 2:00:00 PM
NBIX,SVB Securities Remains a Hold on Neurocrine (NBIX),11/2/2022 12:36:37 PM
NBIX,"Neurocrine stock jumps on raised sales outlook for Ingrezza, Q3 revenue up 31%",11/1/2022 4:14:28 PM
NBIX,Here's what Wall Street expects from Neurocrine Biosciences's earnings,10/31/2022 3:01:13 PM
NBIX,Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating NBI-1117568 in Adults with Schizophrenia,10/27/2022 2:30:00 PM
NBIX,Neurocrine Biosciences Presents Real-World Parkinson's Disease Patient Characteristics From ONGENTYS® (opicapone) Open-Label Study at ANA2022,10/24/2022 2:30:00 PM
NBIX,Neurocrine Biosciences Presents Data on Benztropine Use Among People Treated with Antipsychotics at the 2022 American Psychiatric Nurses Association (APNA) Annual Conference,10/19/2022 2:30:00 PM
NBIX,Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2022 Financial Results,10/11/2022 10:01:00 PM
NBIX,Neurocrine Biosciences Appoints Dr. Ingrid Delaet as Chief Regulatory Officer,9/29/2022 5:00:00 PM
NBIX,4 Analysts Have This to Say About Neurocrine Biosciences,9/26/2022 4:43:55 PM
NBIX,Neurocrine Biosciences Presents INGREZZA® (valbenazine) Data on Sustained Treatment Response at Psych Congress 2022,9/19/2022 2:30:00 PM
NBIX,Neurocrine Biosciences to Present Study Findings on Evolving Tardive Dyskinesia Education Needs of Physicians at the 2022 MDS International Congress,9/15/2022 2:45:00 PM
NBIX,Parkinson & Movement Disorder (PMD) Alliance and Neurocrine Biosciences Announce New Survey Results Revealing the Significant Impact OFF Time Has on People with Parkinson's Disease and Their Care ...,9/12/2022 2:30:00 PM
NBIX,Neurocrine Biosciences to Present at the Morgan Stanley 20th Annual Global Healthcare Conference,9/6/2022 10:01:00 PM
NBIX,Neurocrine to acquire U.K.-based biotech Diurnal,8/30/2022 11:32:08 AM
NBIX,Novartis halts dosing in trial for Huntington’s disease candidate after side effects,8/24/2022 4:09:29 PM
NBIX,"Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases",8/5/2022 5:35:25 PM
NBIX,Neurocrine Biosciences Inc Q2 Earnings Summary,8/4/2022 10:07:55 PM
NBIX,Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2022 Financial Results,7/14/2022 10:01:00 PM
NBIX,Needham Previews Neurocrine's Upcoming Mid-Stage Data from Essential Tremor Study,7/11/2022 8:20:12 PM
NBIX,Neurocrine Biosciences Presents Data on Treatment of Adolescent Patients with Classic Congenital Adrenal Hyperplasia at ENDO 2022,6/13/2022 2:00:00 PM
NBIX,Neurocrine Biosciences to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference,6/8/2022 10:01:00 PM
NBIX,Neurocrine Biosciences Honored at CARES Foundation 22nd Anniversary Gala,6/6/2022 3:30:00 PM
NBIX,Neurocrine Biosciences to repurchase $179.4M of 2.25% Convertible Senior Notes due 2024,5/25/2022 10:05:11 AM
NBIX,Neurocrine Biosciences Presents New INGREZZA® (valbenazine) Data on Tardive Dyskinesia Improvement and Stability of Psychiatric Symptoms at American Psychiatric Association Annual Meeting 2022,5/23/2022 2:30:00 PM
NBIX,"The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product",5/13/2022 4:38:25 PM
NBIX,Pfizer deal to buy Biohaven rallies biotech,5/10/2022 2:14:32 PM
NBIX,"Neurocrine Biosciences Inc Q1 Profit Decreases, misses estimates",5/4/2022 1:40:17 PM
NBIX,Neurocrine Biosciences to Present at the Bank of America Securities 2022 Healthcare Conference,5/3/2022 10:01:00 PM
NBIX,Neurocrine Biosciences Honors Mental Health Awareness Month and Fifth Anniversary of Tardive Dyskinesia Awareness Week,5/2/2022 2:30:00 PM
NBIX,Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2022 Financial Results,4/13/2022 10:01:00 PM
NBIX,Goldman screens companies with best and worst pricing power into earnings season,4/11/2022 11:48:55 AM
NBIX,What 8 Analyst Ratings Have To Say About Neurocrine Biosciences,4/4/2022 4:06:49 PM
NBIX,Neurocrine Biosciences Reports Positive Data Of Valbenazine For Chorea In Huntington Disease ,4/1/2022 3:12:42 PM
NBIX,"The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia",3/29/2022 1:41:44 PM
NBIX,Neurocrine Biosciences Announces Regulatory Approval of Dysval® (valbenazine) for the Treatment of Tardive Dyskinesia in Japan,3/28/2022 10:36:00 PM
NBIX,Neurocrine Biosciences to Present Data from Movement Disorder Portfolio at the American Academy of Neurology 2022 In-Person and Virtual Annual Meeting,3/24/2022 1:30:00 PM
NBIX,Neurocrine Biosciences to Present at Stifel 2022 CNS Days,3/21/2022 9:01:00 PM
NBIX,Neurocrine Biosciences cut to neutral at Piper on growth trajectory of Ingrezza,3/3/2022 8:23:48 PM
NBIX,Neurocrine Biosciences to Present at Upcoming Healthcare Conferences,3/1/2022 10:01:00 PM
NBIX,Where Neurocrine Biosciences Stands With Analysts,2/25/2022 8:05:22 PM
NBIX,Neurocrine spikes to record biggest gain in 10 months despite quarterly miss,2/11/2022 4:30:39 PM
NBIX,Neurocrine Biosciences Q4 2021 Earnings Preview,2/10/2022 4:58:16 PM
NBIX,Analyst Ratings For Neurocrine Biosciences,2/1/2022 6:06:55 PM
NBIX,Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2021 Financial Results,1/25/2022 10:01:00 PM
NBIX,Neurocrine Biosciences downgraded at RBC on lack of near-term catalysts,1/18/2022 6:48:34 PM
NBIX,Xenon Receives $15M Regulatory Milestone Under Epilepsy Pact With Neurocrine,1/12/2022 4:43:55 PM
NBIX,Analyst Ratings For Neurocrine Biosciences,1/7/2022 10:25:19 PM
NBIX,Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2021  Net Product Sales Results and Future Program Milestones,1/6/2022 10:01:00 PM
NBIX,Neurocrine Biosciences to Present at the 40th Annual J.P. Morgan Healthcare Conference,1/3/2022 10:01:00 PM
NBIX,Neurocrine gains as Cantor calls valbenazine data “game changer” in Huntington's Disease,12/8/2021 5:46:52 PM
NBIX,Neurocrine's Ingrezza meets primary endpoint in late-stage Huntington's trial,12/7/2021 10:36:33 PM
NBIX,"Neurocrine Biosciences Appoints Jude Onyia, Ph.D., as Chief Scientific Officer",11/30/2021 10:05:00 PM
NBIX,Sosei Reaches Deal With Neurocrine On Neuropsychiatric Disorders; Eligible To Receive Up To $2.6 Bln ,11/22/2021 2:55:41 PM
NBIX,"Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021",11/19/2021 4:08:55 PM
NBIX,BMO initiates Neurocrine Biosciences at underperform on weak Ingrezza sales,11/18/2021 10:01:14 PM
NBIX,Analyst Ratings For Neurocrine Biosciences,11/17/2021 6:09:06 PM
NBIX,Neurocrine Biosciences to Present at Upcoming Healthcare Conferences,11/9/2021 10:01:00 PM
NBIX,71 Biggest Movers From Yesterday,11/3/2021 8:40:30 AM
NBIX,51 Stocks Moving In Tuesday's Mid-Day Session,11/2/2021 5:06:14 PM
NBIX,Neurocrine Biosciences Inc Q3 adjusted earnings Beat Estimates,11/1/2021 9:07:12 PM
NBIX,Neurocrine Biosciences Q3 2021 Earnings Preview,10/31/2021 9:35:00 PM
NBIX,Neurocrine Biosciences to Present ONGENTYS® (opicapone) and INGREZZA® (valbenazine) Data at the American Neurological Association 2021 Virtual Annual Meeting,10/16/2021 11:00:00 PM
NBIX,"Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021",10/14/2021 5:18:23 PM
NBIX,Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2021 Financial Results,10/11/2021 10:01:00 PM
NBIX,Neurocrine Biosciences Expands Monumental Moments™ Program With World-Renowned Artist Jorge Rodriguez-Gerada to Raise Mental Health Awareness and Honor Those Impacted by the Pandemic,10/8/2021 1:29:00 PM
NBIX,"Biotech's big fall catalysts to watch out for, from Evercore",9/24/2021 1:35:37 PM
NBIX,"Biogen, Sage are new buys as Needham initiates coverage on neuro-focused stocks",9/23/2021 12:43:35 PM
NBIX,Neurocrine To Present Data From Movement Disorder Treatments For TD & Parkinson's Disease ,9/10/2021 3:54:04 PM
NBIX,Neurocrine Biosciences to Present at Upcoming Healthcare Conferences,9/2/2021 10:13:00 PM
NBIX,"The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO",8/13/2021 1:43:02 PM
NBIX,"The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma",8/12/2021 2:09:26 PM
NBIX,"The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering",8/11/2021 2:14:38 PM
NBIX,"Benzinga's Top Ratings Upgrades, Downgrades For August 6, 2021",8/6/2021 4:06:00 PM
NBIX,Neurocrine Biosciences Announces Completion of Enrollment in Phase 3 KINECT-HD Study Evaluating Valbenazine for Chorea in Huntington Disease,8/5/2021 10:01:00 PM
NBIX,Neurocrine Biosciences Inc Q2 adjusted earnings Beat Estimates,8/3/2021 10:11:02 PM
NBIX,Notable earnings after Tuesday's close,8/2/2021 9:35:38 PM
NBIX,Neurocrine Biosciences earnings preview: what Wall Street is expecting,8/1/2021 3:01:51 PM
NBIX,Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2021 Financial Results,7/19/2021 10:01:00 PM
NBIX,Neurocrine Biosciences to Participate at the William Blair Biotech Focus Conference,7/8/2021 10:01:00 PM
NBIX,4 Stocks to Boost Your Portfolio (In an Unintuitive Way),6/21/2021 9:19:23 PM
NBIX,OBSV Stock: The Big Clinical Trial News Boosting ObsEva Today,5/20/2021 12:27:47 PM
NBIX,"Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2021",5/6/2021 4:06:40 PM
NBIX,Neurocrine Biosciences Inc Q1 adjusted earnings Miss Estimates,5/5/2021 10:09:13 PM
NBIX,Notable earnings after Wednesday's close,5/4/2021 9:35:29 PM
NBIX,Here's what to expect from Neurocrine Biosciences's earnings,5/3/2021 3:01:44 PM
NBIX,"Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge",5/1/2021 7:19:25 PM
NBIX,Neurocrine Biosciences and Sentia Medical ink research collaboration agreement,4/26/2021 8:05:59 PM
NBIX,"The Daily Biotech Pulse: Bristol-Myers Squibb's Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq Debut",3/25/2021 12:58:24 PM
NBIX,Neurocrine shares fall after mid-stage schizophrenia study results,3/2/2021 3:46:03 PM
NBIX,Neurocrine’s revenue miss: Baird expects a rebound in 2021,2/5/2021 8:40:17 PM
NBIX,Neurocrine Biosciences Inc Q4 adjusted earnings Beat Estimates,2/4/2021 10:05:51 PM
NBIX,Neurocrine Biosciences Q4 2020 Earnings Preview,2/3/2021 10:35:34 PM
NBIX,Voyager gets termination notice for Neurocrine Parkinson’s collaboration,2/2/2021 9:13:04 PM
NBIX,"The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs And More",1/30/2021 7:19:15 PM
NBIX,Neurocrine Biosciences Preliminary Full-Year INGREZZA Net Product Sales Up 32% ,1/8/2021 1:40:43 PM
NBIX,Seeking Alpha Catalyst Watch,12/31/2020 6:30:40 PM
NBIX,"The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut",12/23/2020 2:30:53 PM
NBIX,FDA puts clinical hold on Neurocrine/Voyager's Parkinson's gene therapy trial,12/22/2020 9:37:26 PM
NBIX,Neurocrine Biosciences Inc Q3 adjusted earnings Beat Estimates,11/9/2020 10:04:27 PM
NBIX,Notable earnings after Monday's close,11/8/2020 10:35:37 PM
NBIX,3 Companies to Invest In for Mammoth Growth in 2021,10/20/2020 7:03:21 PM
NBIX,Baird keeps upbeat outlook on this gene therapy company despite FDA hurdle,10/13/2020 11:28:40 PM
NBIX,"Pre-market Movers In Healthcare Sector: VBIV, ADMA, NBIX, ONCT... ",8/28/2020 12:35:04 PM
NBIX,Neurocrine Biosciences Inc Q2 adjusted earnings Beat Estimates,8/3/2020 10:04:25 PM
NBIX,Neurocrine Biosciences earnings preview: what to expect,8/2/2020 3:01:28 PM
NBIX,"AMRN Makes Peace With Apotex, IDYA Cuts Deal With GSK, SLRX On Watch, NBIX, TAK Ink $2Bln Pact ",6/17/2020 7:25:36 AM
NBIX,Takeda Grants License To Neurocrine Biosciences For Seven Pipeline Programs ,6/16/2020 1:15:43 PM
NBIX,Neurocrine Biosciences Releases Data From Phase II Study Of Crinecerfont ,6/8/2020 7:43:19 PM
NBIX,FDA Oks AbbVie's Oriahnn To Treat Heavy Menstrual Bleeding Associated With Fibroids In Women ,5/30/2020 6:14:08 AM
NBIX,"Neurocrine Biosciences EPS beats by $0.23, beats on revenue",5/6/2020 8:11:04 PM
NBIX,Here's what to expect from Neurocrine Biosciences's earnings report,5/5/2020 3:01:45 PM
NBIX,Neurocrine : FDA Approves Ongentys As Add-On Treatment For Parkinson's Disease ,4/27/2020 1:58:21 PM
NBIX,7 Beautiful Biotech Stocks to Buy Here,4/24/2020 3:41:09 PM
NBIX,Neurocrine Bio suspends enrollment in key study amid COVID-19,4/3/2020 12:54:52 PM
NBIX,Selloff creating bargains in healthcare - Baird,3/25/2020 5:54:57 PM
NBIX,Goldman likes GW Pharma in premarket analyst action,3/6/2020 12:22:23 PM
NBIX,Neurocrine Biosciences Inc Q4 adjusted earnings Beat Estimates,2/4/2020 10:04:28 PM
NBIX,Here's what to expect from Neurocrine Biosciences's earnings report,2/3/2020 3:01:44 PM
NBIX,"Neurocrine Biosciences, Idorsia Amend Option Agreement To License ACT-709478 ",1/10/2020 7:16:14 AM
NBIX,Neurocrine Biosciences Inc Reveals Rise In Q3 Earnings,11/4/2019 10:04:25 PM
NBIX,"ALKS Settles Patent Suit, Once-Monthly Contraceptive In The Works, NBIX On Watch ",7/30/2019 9:07:11 AM
NBIX,EARNINGS SUMMARY: Details of Neurocrine Biosciences Inc Q2 Earnings Report,7/29/2019 10:04:02 PM
NBIX,Neurocrine Biosciences earnings: here's what Wall Street expects,7/27/2019 3:01:30 PM
NBIX,8 Stocks to Buy That Are Growing Faster Than Amazon,7/19/2019 7:40:26 PM
NBIX,EARNINGS SUMMARY: Details of Neurocrine Biosciences Inc Q1 Earnings Report,4/29/2019 10:05:13 PM
NBIX,Neurocrine Biosciences is about to announce earnings — here's what Wall Street expects,4/27/2019 3:01:40 PM
NBIX,Neurocrine Announces Interim Results From Phase II Study Of NBI-74788 ,3/12/2019 1:07:15 PM
NBIX,Neurocrine Biosciences Inc Q4 Earnings Rise,2/5/2019 10:09:16 PM
NBIX,What Wall Street expects from Neurocrine Biosciences's earnings,2/3/2019 3:01:40 PM
NBIX,"What's Making News At VYGR, NVCN, OCX, OrganiGram? ",1/29/2019 2:36:17 PM
NBIX,Neurocrine Biosciences Sees Higher Net Product Sale In Q4 ,1/7/2019 1:49:25 AM
NBIX,"AGTC Slumps After-hrs, NBIX Fails To Strike GOLD, IDRA To Report Data On Dec.14 ",12/13/2018 6:03:22 AM
NBIX,Neurocrine Biosciences Announces Data From Phase IIb T-Force GOLD Study ,12/12/2018 1:52:11 PM
NBIX,EARNINGS SUMMARY: Details of Neurocrine Biosciences Inc Q3 Earnings Report,11/5/2018 10:03:32 PM
NBIX,Neurocrine Biosciences earnings preview: what Wall Street is expecting,11/3/2018 3:01:32 PM
NBIX,"CMTA Fast Tracks NDA Filing, USNA In Good Health, DERM To Report Data In Apr. ",10/24/2018 7:39:15 AM
NBIX,AbbVie Announces Positive Results From Phase 3 Extension Study On Elagolix ,8/22/2018 2:39:48 PM
NBIX,"MOH Boosts Outlook, NBIX Hits All-time High, ACER To Submit Its First NDA In Q4 ",8/2/2018 3:17:43 AM
NBIX,EARNINGS SUMMARY: Details of Neurocrine Biosciences Inc Q2 Earnings Report,7/31/2018 10:07:37 PM
NBIX,Here's what Wall Street expects from Neurocrine Biosciences's earnings report,7/29/2018 3:02:00 PM
NBIX,AbbVie Reports FDA Approval Of ORILISSA - Quick Facts ,7/24/2018 2:40:21 PM
NBIX,Biotech Stocks Facing FDA Decision In July ,6/29/2018 2:19:39 PM
NBIX,"Chief Executive Officer of Neurocrine Biosciences, Kevin Gorman, Ph.D., Named EY Entrepreneur Of The Year® 2018 San Diego",6/8/2018 10:56:00 PM
NBIX,Neurocrine Biosciences to Present at the Bank of America Merrill Lynch 2018 Healthcare Conference,5/9/2018 10:01:00 PM
NBIX,"Neurocrine Biosciences Presents New Quality of Life Data from RE-KINECT, the Largest Real-World Screening Study of Possible Tardive Dyskinesia in Patients Treated with Antipsychotics",5/8/2018 8:00:00 PM
NBIX,American Homes 4 Rent Reports First Quarter 2018 Financial and Operating Results,5/3/2018 11:00:00 PM
NBIX,"Neurocrine Biosciences to Present New Data from RE-KINECT, the Largest Real-World Screening Study of Possible Tardive Dyskinesia Patients, at the 2018 American Psychiatric Association Annual Meeting",5/2/2018 10:14:00 PM
NBIX,EARNINGS SUMMARY: Details of Neurocrine Biosciences Inc Q1 Earnings Report,4/30/2018 10:05:40 PM
NBIX,AbbVie Presents New Investigational Data For Elagolix ,4/27/2018 2:18:02 PM
NBIX,Neurocrine Biosciences Presents New Data Analyses at AAN Annual Meeting Demonstrating INGREZZA® Improved Tardive Dyskinesia Symptoms Across Body Regions,4/26/2018 12:56:00 AM
NBIX,Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2018 Financial Results,4/23/2018 10:01:00 PM
NBIX,"An Ear To The Pharma: 10 Stocks To Watch (BHVN, LLY, TOCA, ALDR…) ",4/21/2018 3:23:59 AM
NBIX,Neurocrine Biosciences to Present New Data from INGREZZA® at the 2018 American Academy of Neurology Annual Meeting,4/18/2018 10:01:00 PM
NBIX,"AGTC Awaits Gene Therapy Data, FDA Delays Decision On Elagolix, KPTI On Watch ",4/11/2018 6:55:59 AM
NBIX,BRIEF-Abbvie And Neurocrine Biosciences Announce PDUFA Target Date Of Q3 2018 For Elagolix In Endometriosis Associated Pain,4/10/2018 2:31:50 PM
NBIX,Will These Drugs Reach Blockbuster Status? ,4/3/2018 1:54:24 PM
NBIX,Neurocrine Biosciences to Present at Upcoming Healthcare Conferences,3/7/2018 7:15:00 PM
NBIX,AbbVie Reports Positive Topline Results From Phase 3 Elagolix Study ,2/21/2018 2:13:09 PM
NBIX,Neurocrine Biosciences Will File New Drug Application for Opicapone for Parkinson's Disease Based on Existing Pivotal Clinical Trial Data,2/14/2018 10:01:00 PM
NBIX,EARNINGS SUMMARY: Details of Neurocrine Biosciences Inc Q4 Earnings Report,2/13/2018 10:05:57 PM
NBIX,Neurocrine Biosciences to Present at the Leerink Partners 7th Annual Global Healthcare Conference,2/8/2018 7:15:00 PM
NBIX,Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2017 Financial Results,2/6/2018 7:15:00 PM
NBIX,"Hyundai's Super Bowl LII Commercial: ""Hope Detector""",2/5/2018 1:40:00 AM
NBIX,"CELG Makes Blockbuster Purchase, MDXG, NBIX On Watch, Busy Year Ahead For ALNY ",1/8/2018 4:58:56 AM
NBIX,"Neurocrine Biosciences Announces Retirement of Christopher O'Brien, M.D., and Appointment of Eiry W. Roberts, M.D., as Chief Medical Officer",1/7/2018 7:01:00 PM
NBIX,LiveXLive Acquires Slacker Radio,1/5/2018 5:06:00 PM
NBIX,Neurocrine Biosciences to Present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference,12/7/2017 7:15:00 PM
NBIX,BRIEF-Neurocrine Biosciences Presents Long-Term Data Analyses From Open-Label Kinect 4 Phase III Study (NBIX),12/4/2017 10:17:06 PM
NBIX,Neurocrine Biosciences to Present New Long-Term Data Evaluating INGREZZA® for the Treatment of Tardive Dyskinesia at the American College of Neuropsychopharmacology Annual Meeting,11/29/2017 10:01:00 PM
NBIX,Neurocrine Biosciences to Present at the 29th Annual Piper Jaffray Healthcare Conference,11/21/2017 7:15:00 PM
NBIX,BRIEF-Neurocrine Biosciences appoints Matt Abernethy as CFO (NBIX),11/20/2017 11:52:03 PM
NBIX,Neurocrine Announces Long-Term Results Evaluating INGREZZA® for the Treatment of Adults with Tardive Dyskinesia Published in the Journal of Clinical Psychiatry,11/14/2017 7:34:00 PM
NBIX,"INGREZZA®, First FDA Approved Product for the Treatment of Tardive Dyskinesia, Receives Outstanding Therapeutic Product Award from Prestigious California Life Sciences Association",11/9/2017 10:01:00 PM
NBIX,Neurocrine Biosciences to Present at the Jefferies 2017 London Healthcare Conference,11/8/2017 7:15:00 PM
NBIX,Neurocrine to Present Data on the Patient Impact of Tardive Dyskinesia from the RE-KINECT Study at the 2017 Neuroscience Education Institute Congress,11/7/2017 10:01:00 PM
NBIX,"DRNA Soars On NASH Deal, JUNO Transcends Expectations, FMI On Solid Footing ",11/3/2017 3:51:17 AM
NBIX,"NBIX Delivers, MNTA's Biosimilar Drug Trial Fails, No FDA Panel Meet For RARE ",11/2/2017 7:37:43 AM
NBIX,EARNINGS SUMMARY: Details of Neurocrine Biosciences Inc Q3 Earnings Report,11/1/2017 9:04:05 PM
NBIX,Neurocrine Biosciences to Present at the Credit Suisse 26th Annual Healthcare Conference,10/31/2017 6:15:00 PM
NBIX,"FDA To Rule On Elagolix In Q2, More Light From CELG's RADIANCE, TGTX On Watch ",10/30/2017 4:00:28 AM
NBIX,BRIEF-Abbvie receives U.S. FDA priority review for investigational Oral Treatment Elagolix (NBIX),10/27/2017 1:42:10 PM
NBIX,BRIEF-Neurocrine initiates Phase IIb clinical study of Ingrezza (NBIX),10/25/2017 10:17:18 PM
NBIX,Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2017 Results,10/24/2017 7:23:00 PM
NBIX,BRIEF-Neurocrine granted FDA orphan drug designation for Valbenazine (NBIX),10/23/2017 11:02:10 PM
NBIX,BRIEF-Neurocrine Biosciences says David-Alexander Gros resigns as COO and interim CFO of co (NBIX),10/19/2017 11:57:15 PM
NBIX,"BRIEF-Neurocrine Biosciences establishes wholesale acquisition cost for a 30-count bottle of Ingrezza 80mg capsules at $6,225 (NBIX)",10/5/2017 3:02:04 PM
NBIX,"Breakfast Technical Briefing on Generic Drugs Stocks -- Mallinckrodt, Horizon Pharma, Mylan, and Neurocrine Biosciences",9/18/2017 12:25:00 PM
NBIX,Neurocrine Announces Data on the Real-World Patient Impact of TD from the RE-KINECT Study to be Presented at the 2017 Annual Psych Congress,9/15/2017 3:25:00 PM
NBIX,Beyond20 Senior Advisor Selected to Speak on Building a Unified Service Catalog at the 2017 Cherwell Global Conference,9/14/2017 10:21:00 PM
NBIX,BRIEF-Perceptive Advisors reports 5.3 pct passive stake in Neurocrine Biosciences (NBIX),9/8/2017 3:12:03 PM
NBIX,AbbVie Submits New Drug Application to U.S. FDA for Investigational Oral Treatment Elagolix for the Management of Endometriosis with Associated Pain,9/6/2017 2:01:00 PM
NBIX,Taco Bell's Naked Egg Taco Revealed On Menus Nationwide,8/31/2017 2:00:00 PM
NBIX,Neurocrine Biosciences to Present at the Baird 2017 Global Healthcare Conference,8/30/2017 7:00:00 PM
NBIX,"Breakfast Technical Briefing on Generic Drugs Stocks -- Horizon Pharma, Mylan, Neurocrine Biosciences, and Rigel Pharma",8/14/2017 12:10:00 PM
NBIX,EARNINGS SUMMARY: Details of Neurocrine Biosciences Inc Q2 Earnings Report,8/3/2017 10:50:13 PM
NBIX,"BRIEF-Neurocrine Biosciences says on July 10, co, Patheon UK Ltd entered into amended, restated product agreement to product agreement entered into on Nov 28 (NBIX)",7/12/2017 11:24:06 PM
NBIX,BRIEF-Neurocrine Biosciences says PDUFA goal date is Oct. 14 for Ingrezza 80 mg capsules (NBIX),7/5/2017 1:32:03 PM
NBIX,Neurocrine Biosciences to Present at the Goldman Sachs 38th Annual Global Healthcare Conference,6/9/2017 7:00:00 PM
NBIX,Neurocrine Announces Presentations Related to INGREZZA® (valbenazine) Capsules at the 21st International Congress of Parkinson's Disease and Movement Disorders,6/2/2017 3:25:00 PM
NBIX,Neurocrine Biosciences to Present at the Jefferies 2017 Global Healthcare Conference,6/1/2017 10:18:00 PM
NBIX,"Technical Reports on Generic Drugs Stocks -- Mylan, Allergan, Horizon Pharma, and Neurocrine Biosciences",5/30/2017 12:10:00 PM
NBIX,"Gainers & Losers Of May 24: PBYI, INO, NVCR, AKAO, NBIX... ",5/25/2017 3:53:19 AM
NBIX,"MRK's Keytruda Scores Another FDA Nod, NBIX Disappoints, SBPH Achieves It ",5/24/2017 7:25:21 AM
NBIX,Neurocrine Biosciences to Present at the Bank of America Merrill Lynch 2017 Healthcare Conference,5/11/2017 9:00:00 PM
NBIX,BRIEF-Neurocrine Biosciences reports Q1 loss per share $0.90 (NBIX),5/9/2017 10:56:02 PM
NBIX,Neurocrine Biosciences Announces Conference Call and Webcast to Report First Quarter 2017 Results,5/3/2017 7:00:00 PM
NBIX,"Neurocrine Biosciences, Inc. Announces Closing of Offering of $517.5 Million of Convertible Senior Notes",5/2/2017 11:04:00 PM
NBIX,BRIEF-Neurocrine Biosciences prices $450 mln convertible senior notes offering (NBIX),4/27/2017 1:19:11 AM
NBIX,BRIEF-Neurocrine announces proposed convertible senior notes offering (NBIX),4/25/2017 10:29:08 PM
NBIX,"How These Generic Drugs Stocks are Faring? -- Evoke Pharma, Neurocrine Biosciences, Lannett, and Catalent",4/24/2017 12:20:00 PM
NBIX,Neurocrine Announces INGREZZA™ Long-Term Safety and Efficacy Data to be Presented at the 2017 American Academy of Neurology Annual Meeting,4/21/2017 12:00:00 PM
NBIX,FusionStorm Renews Cisco Master Cloud Builder Specialization,4/13/2017 7:56:00 PM
NBIX,"The FDA just approved a new drug to treat a serious side effect to certain medications (NBIX, TEVA)",4/12/2017 2:51:43 PM
NBIX,Neurocrine Biosciences gets FDA OK for movement disorder drug,4/11/2017 11:37:02 PM
NBIX,"AKRX Confirms Acquisition Talks, CBIO Plunges, Be All Ears For GERN ",4/10/2017 1:30:22 AM
NBIX,BRIEF-Abbvie announces positive phase 2B data on investigational medicine Elagolix (NBIX),4/7/2017 2:44:53 PM
NBIX,Biotech Stocks Facing FDA Decision In April ,3/24/2017 11:33:55 AM
NBIX,BRIEF-Neurocrine Biosciences reports positive results from study of Ingrezza (NBIX),3/21/2017 2:14:04 PM
NBIX,"How These Generic Drugs Stocks are Faring? -- Neurocrine Biosciences, Lannett, Rigel Pharma, and Catalent",3/17/2017 1:00:00 PM
NBIX,BRIEF-Neurocrine Biosciences reports Q4 loss per share $0.51 (NBIX),2/14/2017 10:32:10 PM
NBIX,BRIEF-Neurocrine and Bial reports exclusive North American licensing agreement for opicapone (NBIX),2/9/2017 10:20:09 PM
NBIX,"BRIEF-Jana Partners cuts sole share stake in Alphabet, takes sole share stake in Mondelez International (NUVA, AN, NBIX)",11/14/2016 3:20:17 PM
NBIX,BRIEF-AbbVie announces positive pivotal phase 3 data for elagolix (NBIX),10/19/2016 7:20:20 PM
NBIX,BRIEF-Neurocrine says INGREZZA NDA for treatment of tardive dyskinesia has been accepted for priority review by U.S. FDA (NBIX),10/11/2016 2:30:22 PM
